Meningitis Outbreak: Six Cases in Haute-Garonne, Adolescent Vaccination Recommended
- As of Monday, a meaningful vaccination campaign targeting meningococcus B has commenced in Rennes, focusing on individuals aged 15-24.
- In the previous year, France reported 615 cases of invasive meningococcal infections, "corresponding to the largest annual number of cases since 2010," according to Santé publique France.
- Although the Occitanie region has not experienced a surge in cases this year, it has not been entirely unaffected.
Meningitis Vaccination Campaigns Intensify Amidst Regional Case Updates
Table of Contents
- Meningitis Vaccination Campaigns Intensify Amidst Regional Case Updates
- Meningitis Vaccinations: Your Questions Answered Amidst Outbreak Concerns
- What is Meningitis and Why is it a Concern?
- What are the Different Types of Meningococcal Vaccines?
- Why are Meningitis Vaccination Campaigns Intensifying?
- What is the Meningitis Situation in France, Specifically in Occitanie?
- What Meningitis Vaccinations are Mandatory in France?
- What are the Vaccination Recommendations for Adolescents?
- What is the Vaccination Coverage in Haute-garonne?
- How Effective are Meningitis Vaccines?
- What are the Symptoms of Meningitis?
- What are the Main Types of Meningitis Vaccines Available?
While France sees a resurgence in meningitis cases, Occitanie reports fewer cases compared to last year. Health authorities emphasize adolescent vaccination.
As of Monday, a meaningful vaccination campaign targeting meningococcus B has commenced in Rennes, focusing on individuals aged 15-24. This initiative follows several infections detected since December, including a case that led to the death of an 18-year-old in early Febuary. The Regional Health Agency aims to reach 100,000 young people through this campaign.
Occitanie Records Twelve Cases As January
In the previous year, France reported 615 cases of invasive meningococcal infections, “corresponding to the largest annual number of cases since 2010,” according to Santé publique France. Their bulletin further noted ”an important resurgence of invasive meningococcal infections during the 2024-2025 season with an exceptionally high number of cases in January 2025.”
Although the Occitanie region has not experienced a surge in cases this year, it has not been entirely unaffected. Dr. Adrian Kriche from the health monitoring unit of the Regional Health agency of Occitanie stated, “Twelve cases have been reported in the region, resulting in two deaths. In Haute-Garonne, six cases were identified, and a 70-year-old person died. This infection occurs annually,and to date,Occitanie has recorded fewer cases than last year.”
Decline in Cases Following Mandatory Vaccination
While the infection remains rare, it is indeed fatal in 15.38% of regional cases this year. The doctor further explained, “That’s why self”>vaccination of infants has become mandatory. Since 2018, this has been the case for meningococcus C, replaced by tetravalent ACWY vaccination since January 1, 2025. And vaccination of all babies against meningococcus B has also been mandatory as the beginning of the year.” The goal is to achieve self”>vaccination coverage that limits cases, especially among young children with immature immune systems. In 2016, meningococcus C accounted for 25% of infections, especially affecting children. Now, with mandatory vaccination in place for seven years, that figure has dropped to 1%.
The recommendation is for all adolescents aged 11 to 14 to receive an ACWY vaccination, regardless of prior vaccination status, with a catch-up for those aged 15 to 24.
Consequently, ACWY vaccination is recommended for all adolescents aged 11 to 14, irrespective of their previous vaccination history, with a catch-up provision for those aged 15 to 24. In haute-Garonne in 2023, vaccination coverage among children under 21 months was 87.7%, while it was only 44.3% among 15-19 year olds. adolescents can also receive the meningococcus B vaccine, even though it is indeed not reimbursed.
Meningitis Vaccinations: Your Questions Answered Amidst Outbreak Concerns
Meningitis is a serious illness, and recent updates from France highlight the importance of vaccination. This Q&A provides extensive details about meningitis, focusing on vaccination efforts and recommendations, notably in light of recent regional case updates.
What is Meningitis and Why is it a Concern?
Meningitis is a serious illness typically caused by bacterial or viral infection that inflames the membranes (meninges) surrounding the brain and spinal cord. Bacterial meningitis is a leading cause of bloodstream infections and can be life-threatening if not treated promptly.
Symptoms may include fever, stiff neck, sensitivity to light, headache, nausea, vomiting, and a purple-spotted rash.
What are the Different Types of Meningococcal Vaccines?
Meningitis can be caused by different serogroups or strains of bacteria. Common vaccines protect against these strains:
MenACWY Vaccine: This vaccine protects against serogroups A, C, W, and Y.
meningococcus B Vaccine: This vaccine protects against serogroup B.
MenABCWY Vaccine (Penbraya™): This pentavalent vaccine protects against serogroups A, B, C, W, and Y.It’s an option for individuals needing both MenACWY and MenB vaccines.
Why are Meningitis Vaccination Campaigns Intensifying?
Invasive meningococcal infections have seen a resurgence,with France reporting 615 cases in the past year,the highest annual number as 2010. A meningococcus B vaccination campaign has started in rennes, targeting individuals aged 15-24, following several recent infections including a fatality.
What is the Meningitis Situation in France, Specifically in Occitanie?
While France has seen an overall increase in cases, the Occitanie region reports fewer cases compared to last year.Twelve cases have been reported in Occitanie, resulting in two deaths.In Haute-Garonne, six cases were identified with one death of a 70-year-old person.
What Meningitis Vaccinations are Mandatory in France?
Vaccination of infants has become mandatory in France to combat meningitis.
Meningococcus C: Mandatory since 2018, now replaced by ACWY.
ACWY Vaccination: Mandatory for infants as January 1, 2025.
Meningococcus B: Vaccination is also mandatory for all babies.
What are the Vaccination Recommendations for Adolescents?
ACWY Vaccination: recommended for all adolescents aged 11 to 14, nonetheless of prior vaccination status.
Catch-Up Provision: Available for those aged 15 to 24.
Meningococcus B Vaccine: Adolescents can also receive this vaccine, even though it is indeed not reimbursed.
What is the Vaccination Coverage in Haute-garonne?
In 2023, vaccination coverage in Haute-Garonne shows disparities:
Children under 21 months: 87.7% coverage
15-19 year olds: Only 44.3% coverage
How Effective are Meningitis Vaccines?
Mandatory vaccination has shown significant results. Such as, meningococcus C accounted for 25% of infections in 2016, particularly affecting children. After seven years of mandatory vaccination, that figure has dropped to 1%.
What are the Symptoms of Meningitis?
Meningitis symptoms can appear quickly and may include:
High fever
Severe headache
Stiff neck
Sensitivity to light (photophobia) Confusion or altered mental state
Nausea and vomiting
Seizures
What are the Main Types of Meningitis Vaccines Available?
| Vaccine Type | Protects Against | target Population | Availability |
| —————– | —————- | ———————————————————— | ——————————– |
| MenACWY | A, C, W, and Y | Adolescents (11-14 years), with catch-up for those 15-24 | Recommended, frequently enough reimbursed |
| Meningococcus B | B | Infants (mandatory), Adolescents (not always reimbursed) | Available, but reimbursement varies |
| MenABCWY (Penbraya) | A, B, C, W, and Y | Individuals needing both MenACWY and MenB vaccines | Available |